FORT LEE, N.J.--(BUSINESS WIRE)--Neurologix, Inc. (OTCBB: NRGX), a biotechnology company engaged in the development of innovative gene therapies for the brain and central nervous system, announced today that John Mordock, the company’s President and Chief Executive Officer, will present at the Roth Capital Partners 20th Annual OC Conference. The conference will be held February 18-21 at The Ritz-Carlton, Laguna Niguel in Dana Point, CA.
